RELATIVE BIOAVAILITY OF SIMVASTAIN TABLET IN HEALTHY VOULUNTEERS
Sun Chun
Abstract
Sun Chun
Abstract
A single oral dose of 40mg domestic and imported simvatatin was given to 8 healthy volunteers in a randomized crossover study, simvatatin's active metabolite concentration in plasma were determined by GC/MS method . The pharmacokinetics and bioavailability were studied . The results showed that the plasma concentration_time curves of the two products were all fitted to one-compartment model. Tpeak of domestics and imported tablets were 2.71±0.19 h and 2.69±0.20 h, AUC0-∞ were 19.016±2.255 μg·h· L-1 and 20.444±2.830 μg·h·L-1, Cmax were 1.82±0.23 μg· L-1 and 1.93±0.31 μg· L-1,the relative bioavailability of domestics to imported tablets was 94.9±6.0%. There were no statistically singnificant difference between the two parameters(P0.05). The results demonstrated that two preparations were bioquivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A single oral dose of 40mg domestic and imported simvatatin was given to 8 healthy volunteers in a randomized crossover study, simvatatin's active metabolite concentration in plasma were determined by GC/MS method . The pharmacokinetics and bioavailability were studied . The results showed that the plasma concentration_time curves of the two products were all fitted to one-compartment model. Tpeak of domestics and imported tablets were 2.71±0.19 h and 2.69±0.20 h, AUC0-∞ were 19.016±2.255 μg·h· L-1 and 20.444±2.830 μg·h·L-1, Cmax were 1.82±0.23 μg· L-1 and 1.93±0.31 μg· L-1,the relative bioavailability of domestics to imported tablets was 94.9±6.0%. There were no statistically singnificant difference between the two parameters(P0.05). The results demonstrated that two preparations were bioquivalent.
Key concepts: Bioavailability, Cmax, Pharmacokinetics, Plasma concentration, Active metabolite, Crossover study, Metabolite, Chemistry